Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.
Press releases published on May 13, 2025

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
IND cleared for pan-RAS molecular glue ERAS-0015 and IND submitted for pan-KRAS inhibitor ERAS-4001, both ahead of schedule; Phase 1 monotherapy data for both programs expected in 2026 Meaningful extension of cash runway guidance from H2 2027 to H2 2028 …

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline …

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, …

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst …

Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona
CHANDLER, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces that registration is now open for its MASTERs Conference in North America, the premier technical training event for embedded design engineers. This year …

Reviva to Participate in the A.G.P. Healthcare Company Showcase
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Highwire Appoints Powerhouse Michael O’Brien as CEO
SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Highwire, a strategic marketing communications agency partnering with brands at the intersection of innovation and industry, today announced the appointment of Michael O’Brien as its new chief executive …

Advanced Technology International Acquires Carrot
SUMMERVILLE, S.C., May 13, 2025 (GLOBE NEWSWIRE) -- We are excited to announce that effective March 31, 2025, Advanced Technology International (ATI), a South Carolina based 501(c)3 public service nonprofit, acquired the assets of The Common Pool, LLC, dba …

Lexis+ AI Fuels $30M Revenue Growth in Law Firms, New Study Finds
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- LexisNexis® Legal …

Auto and Property Insurance Shopping in First Quarter 2025 Elevated Compared to One Year Ago
CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Auto insurance shopping in Q1 2025 increased 10% compared to the same period in 2024. Home insurance shopping was up 5% year over year, according to TransUnion (NYSE: TRU) research. While the trend of elevated …

JFB Construction Holdings Awarded $6.7 Million Contract as General Contractor for Courtyard by Marriott Conversion and Remodel
Construction in Melbourne, FL expected to commence in Third Quarter 2025 Lantana, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- JFB Construction Holdings (Nasdaq: JFB), a construction company focused on commercial, retail, and residential property development (“ …

Algorhythm Holdings Announces Major Fleet Expansion for SemiCab India
SemiCab India Adds Additional Truck Capacity with Expansion to Generate Up to $23 Million in Annual Revenue Fort Lauderdale, FL, May 13, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and consumer …

Hour Loop Partners with Return Helper to Tackle the Challenges of a High-Tariff Era
As U.S. tariffs rise and platform competition intensifies, Hour Loop seeks to upgrade supply chain strategy through partnership with Return Helper Redmond, WA, May 13, 2025 (GLOBE NEWSWIRE) -- Hour Loop, Inc. (“Hour Loop” or the “Company”) (NASDAQ: HOUR), …

red violet to Present at the 25th Annual B. Riley Securities Investor Conference
BOCA RATON, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the 25th Annual B. Riley Securities Investor Conference being held May 21-22 …

ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M - - Promising early signal in Cohort P with 90.5% high-grade recurrence free …